CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- 4 Planned sale Director sold 12,500 shares at an average $62.12 ($776,495)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 2,954 shares (option exercise)
- 4 Option exercise Director acquired 1,383 shares (option exercise)
- 4 Planned sale Chief Operating Officer sold 2,989 shares at $66.75 ($199,516)
- 4 Open-market sale Chief Human Resources Officer sold 12,274 shares at an average $68.36 ($839,070)
- 4 Open-market sale General Counsel sold 12,440 shares at an average $68.36 ($850,417)
- 4 Open-market sale Chief Operating Officer sold 11,324 shares at an average $68.21 ($772,444)
- 4 Open-market sale Chief Commercial Officer sold 13,056 shares at an average $68.36 ($892,528)
- 4 Open-market sale Chief Medical Officer sold 1,144 shares at an average $68.36 ($78,204)
- 4 Open-market sale See Remarks sold 6,430 shares at an average $68.36 ($439,566)
- 4 Open-market sale President/CEO and Board Chair sold 34,603 shares at an average $68.34 ($2,364,904)
- 4 Planned sale Director sold 12,500 shares at an average $68.79 ($859,819)
- 4 Option exercise Chief Human Resources Officer acquired 23,909 shares (option exercise)
- 4 Option exercise General Counsel acquired 24,236 shares (option exercise)
- 4 Option exercise Chief Operating Officer acquired 26,287 shares (option exercise)
Page 2 of 17 · 330 filings